In addition, even in patients with PSA level < 4.0 ng/mL, if the next PSA level increases by approximately 20%, our findings suggested that it would be better to perform a biopsy because the risk of developing prostate cancer may increase in the future. This evidence concerns the gene KLK3 and prostate cancer.